ArticleToxics2025
Iron-Manganese-Modified Hydrochar for Synergistic Stabilization of Antimony and Arsenic in Smelter-Impacted Soils.
Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Article
- Synergistic adsorption and oxidation of arsenite by Fe-Mn binary oxide-modified bamboo Biochar in the presence of air.Scientific reports · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Soil co-contamination with antimony (Sb) and arsenic (As) presents significant ecological and human health risks, demanding effective stabilization solutions. This study evaluated iron-manganese-modified hydrochar (FMHC) for synergistic Sb-As stabilization in contaminated smelter soils. Through 60-day natural aging and 30 accelerated aging cycles, we assessed stabilization performance using toxicity leaching tests (acid/water/TCLP), bioavailable fraction analysis, bioaccessibility assessment, and Wenzel sequential extraction. The key findings reveal that FMHC (5 wt%) achieves durable stabilization: (1) leaching concentrations remained stable post-aging (Sb: 0.3-4.5 mg·L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.